Overview of the current use of levosimendan in France: a prospective observational cohort study

Abstract Background Following the results of randomized controlled trials on levosimendan, French health authorities requested an update of the current use and side-effects of this medication on a national scale. Method The France-LEVO registry was a prospective observational cohort study reflecting...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Bernard Cholley, Mirela Bojan, Benoit Guillon, Emmanuel Besnier, Mathieu Mattei, Bruno Levy, Alexandre Ouattara, Nadir Tafer, Clément Delmas, David Tonon, Bertrand Rozec, Jean-Luc Fellahi, Pascal Lim, François Labaste, François Roubille, Thibaut Caruba, Philippe Mauriat, for the ARCOTHOVA study group
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-08-01
Serija:	Annals of Intensive Care
Teme:	Levosimendan Inotropes Heart failure Cardiogenic shock Repetitive infusions VA-ECMO weaning
Online dostop:	https://doi.org/10.1186/s13613-023-01164-3
Oznake:	Označite Brez oznak, prvi označite!